{"disease":{"id":"immunoglobulin-light-chain-amyloidosis","name":"immunoglobulin light chain amyloidosis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04659798","title":"A Study to Investigate the Relationship Between Duration of Treatment and Response in Patients With Multiple Myeloma (MM) or Systemic AL Amyloidosis Treated in Real-life Practice","phase":"","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT05776940","title":"Probiotic Supplementation Reduces Gastrointestinal Symptoms During the Therapy and Improves Therapeutic Response in AL Amyloidosis","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":116,"lead_sponsor_name":"Air Force Military Medical University, China","has_results":false},{"nct_id":"NCT04612582","title":"Comparison of BTD and BCD Based Regimens in the Treatment of AL Amyloidosis","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":70,"lead_sponsor_name":"Guangdong Provincial People's Hospital","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}